The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Selective vulnerability in neurodegenerative diseases
Open accessAbstract
Neurodegenerative diseases have two general characteristics that are so fundamental we usually take them for granted. The first is that the pathology associated with the disease only affects particular neurons ('selective neuronal vulnerability'); the second is that the pathology worsens with time and impacts more regions in a stereotypical and predictable fashion. The mechanisms underpinning selective neuronal and regional vulnerability have been difficult to dissect, but the recent application of whole-genome technologies, the development of mouse models that reproduce spatial and temporal features of the pathology, and the identification of intrinsic morphological, electrophysiological, and biochemical properties of vulnerable neurons are beginning to shed some light on these fundamental features of neurodegenerative diseases. Here we detail our emerging understanding of the underlying biology of selective neuronal vulnerability and outline some of the areas in which our understanding is incomplete.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disease-associated genes are usually expressed by many CNS cell types, but select populations play an outsized role in driving disease progression [48].”
From Elucidating brain transport pathways and cell type-dependent gene silencing of a durable lipid–siRNA conjugate administered into cerebrospinal fluid (2025) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Cryo-EM structures of tau filaments from Alzheimer’s disease
Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061
Ionic dependence of glutamate neurotoxicity
Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854
Research works printed but not linked: 1
- Nitrini, R. Selective vulnerability of von Economo neurons in frontotemporal dementia. Dement. Neuropsychol. 2, 164 (2008).
Cited by
Sorted by citations
Items 201–300 of 603
EEG/ERP evidence of possible hyperexcitability in older adults with elevated beta-amyloid
Devos, H., Gustafson, K. M., Liao, K., Ahmadnezhad, P., Estes, B. J., Martin, L. E., Mahnken, J. D., Brooks, W. M., & Burns, J. M. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00282-5 · Cited by 19
Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease
Donnelly, K. M., Coleman, C. M., Fuller, M. L., Reed, V. L., Smerina, D., Tomlinson, D. S., & Pearce, M. M. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946822 · Cited by 20
Cell competition from development to neurodegeneration
RODRIGUES, M. C., Couceiro, J., & Moreno, E. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048926 · Cited by 22
Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer’s Disease
Adeyemı, O. S., Awakan, O. J., Afolabi, B., Rotimi, D. E., Oluwayemi, E. T., Otuechere, C. A., Ibraheem, O., Elebiyo, T. C., Alejolowo, O. O., & Arowolo, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5522981 · Cited by 20
Hussain, M. S., Chaturvedi, V., Goyal, S., Singh, S., & Mir, R. H. (2023) · Current Bioactive Compounds · doi:10.2174/0115734072258656231013085318 · Cited by 20
Alexander-Floyd, J., Haroon, S., Ying, M., Entezari, A. A., Jaeger, C., Vermulst, M., & Gidalevitz, T. (2020) · BMC Biology · doi:10.1186/s12915-020-0750-5 · Cited by 19
Dávila-Velderrain, J., Mathys, H., Mohammadi, S., Ruzicka, B., Jiang, X., Ng, A. P., Bennett, D. A., Tsai, L., & Kellis, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.01.450715 · Cited by 21
Shimada, M., Omae, Y., Kakita, A., Gabdulkhaev, R., Hitomi, Y., Miyagawa, T., Honda, M., Fujimoto, A., & Tokunaga, K. (2024) · Science Advances · doi:10.1126/sciadv.adj5279 · Cited by 22
Necrosis Links Neurodegeneration and Neuroinflammation in Neurodegenerative Disease
Homma, H., Tanaka, H., Fujita, K., & Okazawa, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073636 · Cited by 20
Modeling neurodevelopment in a dish with pluripotent stem cells
Imaizumi, K., & Okano, H. (2020) · Development Growth & Differentiation · doi:10.1111/dgd.12699 · Cited by 16
Anusha-Kiran, Y., Mol, P., Dey, G., Bhat, F. A., Chatterjee, O., Deolankar, S. C., Philip, M., Prasad, T. S. K., Bharath, M. M. S., & Mahadevan, A. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.027 · Cited by 19
Schuster, K. H., DiFranco, D. M., Putka, A. F., Mato, J. P., Jarrah, S. I., Stec, N. R., Sundararajan, V. O., & McLoughlin, H. S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1118429 · Cited by 19
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
Fodder, K., de Silva, R., Warner, T. T., & Bettencourt, C. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01607-9 · Cited by 22
A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts
Wang, Z., Henriques, A., Rouvière, L., Callizot, N., Tan, L., Hotchkin, M. T., Rossignol, R., Mortenson, M. G., Dorfman, A. R., Ho, K. S., et al. (2023) · Small · doi:10.1002/smll.202304082 · Cited by 18
Sethi, P., Virmani, G., Gupta, K., Thumu, S. C. R., Ramanan, N., & Marathe, S. V. (2021) · Journal of Cell Science · doi:10.1242/jcs.258430 · Cited by 17
Doke, A. A., & Jha, S. K. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.106972 · Cited by 17
Epigenetics in Neurodegenerative Diseases
van Zundert, B., & Montecino, M. A. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_3 · Cited by 18
Lee, W., Lavery, L. A., Rousseaux, M. W. C., Rutledge, E. B., Jang, Y., Wan, Y., Wu, S., Kim, W., Al‐Ramahi, I., Rath, S., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106106 · Cited by 17
Personalised regional modelling predicts tau progression in the human brain
Chaggar, P., Vogel, J. W., Binette, A. P., Thompson, T., Strandberg, O. T., Mattsson, N., Karlsson, L., Stomrud, E., Jbabdi, S., Magon, S., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003241 · Cited by 19
The Proteostasis Network in Proteinopathies
Pytel, D., & Longo, J. F. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.07.011 · Cited by 18
Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer’s disease pathology
Pan, J., Wang, P.-J., Zhang, J., Knapskog, A., Watne, L. O., Wang, H.-L., Lagartos-Donate, M. J., Lautrup, S., Mao, L.-P., Wang, Q., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01108-z · Cited by 20
Montinaro, C., Pisanello, M., Bianco, M., Spagnolo, B., Pisano, F., Balena, A., Nuccio, F. D., Lofrumento, D. D., Verri, T., Vittorio, M. D., et al. (2021) · Biomedical Optics Express · doi:10.1364/boe.439848 · Cited by 16
Jung, R., Lechler, M. C., Fernández‐Villegas, A., Chung, C. W., Jones, H. C., Choi, Y. H., Thompson, M. A., Rödelsperger, C., Röseler, W., Schierle, G. S. K., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002284 · Cited by 31
Chen, C., Lan, Z., Tang, X., Chen, W., Zhou, X. W., Su, H., Su, R., Chen, Z., Chen, H., Guo, Y., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27001 · Cited by 16
Burtscher, J., Pardo, A. D., Maglione, V., Schwarzer, C., & Squitieri, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155412 · Cited by 16
Bansal, K., Singh, V., Singh, S., & Mishra, S. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230320144722 · Cited by 16
Redox biology in neurodegenerative disorders
Abramov, A. Y. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.229 · Cited by 16
Serrano‐Pozo, A., Escott‐Price, V., Grinberg, L. T., Pascoal, T. A., Suárez‐Calvet, M., Dubois, B., & Sperling, R. A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00198-4 · Cited by 20
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
Bender, A., Thomas, M. C., Scannell, J. W., Shaywitz, D. A., Ghiandoni, G. M., Greener, J. G., Pruteanu, L.-L., Jacobson, R. D., Handa, K., Hirano, M., et al. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01496-2 · Cited by 23
Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study
Mattsson, P., Cselényi, Z., Andrée, B., Borg, J., Nag, S., Halldin, C., & Farde, L. (2022) · Synapse · doi:10.1002/syn.22235 · Cited by 15
Ipe, R. S., Kumar, S., Benny, F., Jayan, J., Manoharan, A., Sudevan, S. T., George, G., Gahtori, P., Kim, H., & Mathew, B. (2023) · Pharmaceuticals · doi:10.3390/ph16091310 · Cited by 15
Selective vulnerability of parvocellular oxytocin neurons in social dysfunction
Tsurutani, M., Goto, T., Hagihara, M., Irie, S., & Miyamichi, K. (2024) · Nature Communications · doi:10.1038/s41467-024-53092-w · Cited by 15
Kaczmarczyk, L., Bansal, V., Rajput, A., Rahman, R., Krzyżak, W., Degen, J., Poll, S., Fuhrmann, M., Bonn, S., & Jackson, W. S. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000374 · Cited by 13
Differences in topological progression profile among neurodegenerative diseases from imaging data
Garbarino, S., Lorenzi, M., Oxtoby, N. P., Vinke, E. J., Marinescu, R. V., Eshaghi, A., Ikram, M. A., Niessen, W. J., Ciccarelli, O., Barkhof, F., et al. (2019) · eLife · doi:10.7554/elife.49298 · Cited by 16
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
Coccia, E., & Ahfeldt, T. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02326-5 · Cited by 16
Gray, A. L. H., Sawaya, M. R., Acharyya, D., Lou, J., Edington, E. M., Best, M. D., Prosser, R. A., Eisenberg, D. S., & Do, T. D. (2021) · Protein Science · doi:10.1002/pro.4268 · Cited by 14
Friend or Foe? The Varied Faces of Homeostatic Synaptic Plasticity in Neurodegenerative Disease
Taylor, H. B. C., & Jeans, A. F. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.782768 · Cited by 18
Datta, D., Perone, I., Morozov, Y. M., Arellano, J. I., Duque, A., RAKIC, P. T., van Dyck, C. H., & Arnsten, A. F. T. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad382 · Cited by 16
García, F., & Heiman, M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00799-z · Cited by 14
Ho-Tieng, D., Sharma, V. K., Sonenberg, N., Gkogkas, C. G., & Khoutorsky, A. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.08.002 · Cited by 14
Tau polarizes an aging transcriptional signature to excitatory neurons and glia
Wu, T., Deger, J., Ye, H., Guo, C., Dhindsa, J. S., Pekarek, B. T., Al‐Ouran, R., Liu, Z., Al‐Ramahi, I., Botas, J., et al. (2023) · eLife · doi:10.7554/elife.85251 · Cited by 14
Stauch, K. L., Totusek, S., Trease, A. J., Estrella, L. D., Emanuel, K. M., Fangmeier, A., & Fox, H. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-38484-0 · Cited by 15
Effects and mechanisms of bisphenols exposure on neurodegenerative diseases risk: A systemic review
Xu, Y., Nie, J., Lu, C., Hu, C., Chen, Y., Ma, Y., Huang, Y., & Lu, L. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170670 · Cited by 14
Khandia, R., Sharma, A., Alqahtani, T., Alqahtani, A., Asiri, Y. I., Alqahtani, S., Alharbi, A. M., & Kamal, M. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.887929 · Cited by 14
Kundra, R., Dobson, C. M., & Vendruscolo, M. (2020) · iScience · doi:10.1016/j.isci.2020.100934 · Cited by 16
Genetic Influences on Hippocampal Subfields
Vilor‐Tejedor, N., Evans, T. E., Adams, H. H. H., Gónzalez‐de‐Echávarri, J. M., Molinuevo, J. L., Guigó, R., Gispert, J. D., & Operto, G. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000591 · Cited by 12
Global hippocampal and selective thalamic nuclei atrophy differentiate chronic TBI from Non-TBI
Sandry, J. D., & Dobryakova, E. (2021) · Cortex · doi:10.1016/j.cortex.2021.08.011 · Cited by 15
MAP2 caps tau fibrils and inhibits aggregation
Holden, M. R., Krzesinski, B. J., Weismiller, H. A., Shady, J. R., & Margittai, M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104891 · Cited by 13
Vesicular dysfunction and pathways to neurodegeneration
Lewis, P. A. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210034 · Cited by 13
Andersen, J. V., Marian, O. C., Qvist, F. L., Westi, E. W., Aldana, B. I., Schousboe, A., Don, A. S., Skotte, N. H., & Wellendorph, P. (2024) · Glia · doi:10.1002/glia.24585 · Cited by 13
Wang, J.-L., Ye, C.-H., Teng, Z.-F., Zhou, K., Pan, L.-L., Ouyan, M.-D., Zheng, Z., Meng, L. M., Li, S.-L., Zhang, J., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03103-z · Cited by 13
Kara, E., Crimi, A., Wiedmer, A. E., Emmenegger, M., Manzoni, C., Bandrés‐Ciga, S., D’Sa, K., Reynolds, R. H., Botía, J. A., Losa, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109189 · Cited by 12
Self-citationDeficiency of ER Ca2+ sensor STIM1 in AgRP neurons confers protection against dietary obesity
Chen, Z., Pan, S., Yin, K., Zhang, Y., Yuan, X., Wang, S., Yang, S., Shen, Q. X., Tang, Y., Li, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109868 · Cited by 15
Kawakatsu, S., Kobayashi, R., Hayashi, H., Morioka, D., Utsunomiya, A., Kabasawa, T., Ohe, R., & Otani, K. (2021) · Neuropathology · doi:10.1111/neup.12765 · Cited by 12
A comprehensive bioinformatic analysis revealed novel MicroRNA biomarkers of Parkinson's disease
Rahimpour, A., Heidarzadehpilehrood, R., Abdollahi, S., Ranjbari, H., Shams, Z., Ghasemi, S. A., Najmaei, S., & Pirhoushiaran, M. (2022) · Cell Biology International · doi:10.1002/cbin.11869 · Cited by 13
Chhetri, G., Ke, Y., Wang, P., Usman, M., Li, Y., Sapp, E., Wang, J., Ghosh, A., Islam, M. A., Wang, X., et al. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202112073 · Cited by 12
mRNA isoform balance in neuronal development and disease
LaForce, G. R., Philippidou, P., & Schaffer, A. E. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1762 · Cited by 15
A Multi-Scale Computational Model of Excitotoxic Loss of Dopaminergic Cells in Parkinson's Disease
Muddapu, V. R., & Chakravarthy, V. S. (2020) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2020.00034 · Cited by 12
A molecular census of midbrain dopaminergic neurons in Parkinson’s diseasePreprint
Kamath, T., Abdulraouf, A., Burris, S. J., Gazestani, V., Nadaf, N. M., Vanderburg, C. R., & Macosko, E. Z. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.16.448661 · Cited by 13
An astrocyte-microglia MFG-E8 axis promotes synapse engulfment in early amyloid pathology
Sokolova, D., Puletti, F., Ghansah, S. A., Georgiades, T., Zheng, Y., Wu, L., Schepper, S. D., Lange, J., Ferreira, L. S. S., Sierksma, A., et al. (2026) · Neuron · doi:10.1101/2024.08.31.606944 · Cited by 15
Xia, M., Liu, Q., Zhang, W., Ge, J., & Mei, Z. (2025) · MedComm · doi:10.1002/mco2.70328 · Cited by 15
HnRNP Pathologies in Frontotemporal Lobar Degeneration
Jiang, X., Gatt, A. P., & Lashley, T. (2023) · Cells · doi:10.3390/cells12121633 · Cited by 13
Znaidi, R., Massiani-Beaudoin, O., Mailly, P., Monnet, H., Bonnifet, T., The Brainbank Neuro-CEB Neuropathology Network, Joshi, R. L., & Fuchs, J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149579 · Cited by 14
Using Proteomics to Understand Alzheimer’s Disease Pathogenesis
Drummond, E., & Wısnıewskı, T. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch3 · Cited by 13
Long‐distance regressive signaling in neural development and disease
Pathak, A., Clark, S. A., Bronfman, F. C., Deppmann, C. D., & Carter, B. D. (2020) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.382 · Cited by 12
Nascimento, C. F., Nunes, P. V., Suemoto, C. K., Rodriguez, R. D., Leite, R. E. P., Grinberg, L. T., Pasqualucci, C. A., Nitríni, R., Filho, W. J., Brentani, H., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.034 · Cited by 13
Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review
Golubev, A. G. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101570 · Cited by 12
Reed, A. L., Mitchell, W., Alexandrescu, A. T., & Alder, N. N. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1263420 · Cited by 13
Spirig, S. E., Herrero-Navarro, Á., Utz, L., Arteaga-Moreta, V. J., Raics, Z., Posada-Céspedes, S., Chreng, S., Galuba, O., Galuba, I., Claerr, I., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.024 · Cited by 11
Qi, Y., Klyubin, I. V., Hu, N., Ondrejčák, T., & Rowan, M. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00861 · Cited by 12
Introduction for Stem Cell–Based Therapy for Neurodegenerative Diseases
Han, F., & Lu, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4370-8_1 · Cited by 13
Muñiz, J. A., Facal, C. L., Urrutia, L., Clerici-Delville, R., Damianich, A., Ferrario, J. E., Falasco, G., & Avale, M. E. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.951384 · Cited by 12
Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1)
Hamel, K. A., Labrada-Moncada, F. E., Sheeler, C. A., Rosa, J. S., Gilliat, S., Zhang, Y., & Cvetanović, M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106530 · Cited by 11
Pedroni, A., Dai, Y.-W. E., Lafouasse, L., Chang, W., Srivastava, I., Vecchio, L. D., & Ampatzis, K. (2024) · Nature Communications · doi:10.1038/s41467-024-48729-9 · Cited by 11
Khan, M. A. (2024) · Pharmaceuticals · doi:10.3390/ph17121669 · Cited by 11
Datta, D., & Arnsten, A. F. T. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14477 · Cited by 11
Воронин, М. В., Андреевич, К. И., Зайнуллина, Л. Ф., Логвинов, И. О., Verbovaya, E. R., Антипова, Т. А., Vakhitova, Y. V., & Середенин, С. Б. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313061 · Cited by 11
Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
Torok, J., Anand, C., Verma, P., & Raj, A. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.008 · Cited by 11
Quach, T., Stratton, H. J., Khanna, R., Mackey-Alfonso, S. E., Deems, N., Honnorat, J., Meyer, K., & Duchemin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214188 · Cited by 12
Somatic copy number variant load in neurons of healthy controls and Alzheimer’s disease patients
Turan, Z. G., Richter, V., Bochmann, J., Parvizi, P., Yapar, E., Işıldak, U., Waterholter, S.-K., Leclère-Turbant, S., Son, Ç. D., Duyckaerts, C. J., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01452-2 · Cited by 12
Bionic Opto-Responsive Fiber for Directing Neurite Growth
Müller, C., Li, P., Wang, Y., Dong, M., Tian, B., & Chen, M. (2022) · Materials Today Nano · doi:10.1016/j.mtnano.2023.100311 · Cited by 11
Bose, R., Spulber, S. D., & Ceccatelli, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054338 · Cited by 12
Long-Term Dynamic Changes of NMDA Receptors Following an Excitotoxic Challenge
Granzotto, A., D’Aurora, M., Bomba, M., Gatta, V., ONOFRJ, M. C., & Sensi, S. L. (2022) · Cells · doi:10.3390/cells11050911 · Cited by 9
The brain—from neurodevelopment to neurodegeneration
Abramov, A. Y. (2022) · FEBS Journal · doi:10.1111/febs.16436 · Cited by 11
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Lin, D., Kaye, S. D., Chen, M., Lyanna, A., Ye, L., Hammond, L. A., & Gao, J. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107874 · Cited by 12
Cracking the code: the clinical and molecular impact of aminopyridines; a review (2019–2024)
Khalid, T., Malik, A., Rasool, N., Kanwal, A., Nawaz, H., & Almas, I. (2025) · RSC Advances · doi:10.1039/d4ra07438f · Cited by 12
Lee, E. J., Park, D. Y., Han, J. C., & Kee, C. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101379 · Cited by 13
Matcha and Its Components Control Angiogenic Potential
Ryota, I. W. A. I., Ishii, T., Fukushima, Y., Okamoto, T., Ichihashi, M., Sasaki, Y., & MIZUATNI, K.-I. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.118 · Cited by 15
Garcia, A. X., Xu, J., Cheng, F., Ruppin, E., & Schäffer, A. A. (2023) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12373 · Cited by 9
Toward a new nosology of neurodegenerative diseases
Menéndez‐González, M. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13041 · Cited by 12
Gayen, M., Benoit, M., Fan, Q., Hudobenko, J., & Yan, R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102532 · Cited by 10
Statsenko, Y. A., Meribout, S., Habuza, T., Almansoori, T. M., Gorkom, K., Gelovani, J. G., & Ljubisavljević, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.943566 · Cited by 10
Protein crystals as a key for deciphering macromolecular crowding effects on biological reactions
Ferreira, C., Pinto, M. F., Macedo‐Ribeiro, S., Pereira, P. J. B., Rocha, F. A., & Martins, P. M. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp02469d · Cited by 10
Tissue-specific safety mechanism results in opposite protein aggregation patterns during agingPreprint
Jung, R., Lechler, M. C., Rödelsperger, C., Röseler, W., Sommer, R. J., & David, D. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.04.409771 · Cited by 10
Dysregulation of neuroproteasomes by ApoE isoforms drives endogenous Tau aggregationPreprint
Paradise, V., Sabu, M., Bafia, J., Sharif, N., Nguyen, C., Konrad-Vicario, K., Mukim, R. D., Wang, X., Corjuc, B., Fu, J. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.29.518293 · Cited by 10
Rexach, J. E., Cheng, Y., Chen, L., Polioudakis, D., Lin, L., Mitri, V., Elkins, A. G., Yin, A., Calini, D., Kawaguchi, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.29.560245 · Cited by 10
Patterning the cerebral cortex into distinct functional domains during development
Appan, D., Hsu, S.-M., Hsu, W.-H., & Chou, S. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102698 · Cited by 15
Rubido, N., Riedel, G., & Vuksanović, V. (2023) · Brain Communications · doi:10.1093/braincomms/fcad320 · Cited by 9
Recent Progress in Brain Network Models for Medical Applications: A Review
Ye, C., Zhang, Y., Chen, R., & Ma, T. (2024) · Health Data Science · doi:10.34133/hds.0157 · Cited by 9
Metadata
- Authors
- Fu, H., Hardy, J., & Duff, K. E.
- Affiliations
- Columbia University Irving Medical Center (US)
- UCL Queen Square Institute of Neurology (GB)
- Corresponding author
- Duff, Karen E.
- Venue
- Nature Neuroscience
- Published
- 2018-09-24
- Volume
- 21
- Issue
- 10
- Pages
- 1350-1358
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC6360529
- OpenAlex
- W2890004445
- Cited by
- 585
- References
- 154
- Citations by year
- 2026: 87 · 2025: 78 · 2024: 85 · 2023: 67 · 2022: 83 · 2021: 82 · 2020: 60 · 2019: 39 · 2018: 3
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute on Aging (RF1AG056151, K01AG056673)
- National Institute of Neurological Disorders and Stroke (R01NS074874)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- neurodegenerative diseases, selective neuronal vulnerability, regional vulnerability, disease progression
- MeSH terms
- Animals, Humans, Neurons, Neurodegenerative Diseases, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review